FDA/USDA Regulations - Biotech/Drug Laws

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers. The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant.

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis. Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries. Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date	Title	Organization
16 Sep	Notice Under § 287 Means Knowledge of Infringement, Not Knowledge of Patent	McDermott Will & Emery
16 Sep	Material Information Submitted to FDA but Withheld from PTO Gives Rise to Inequitable Conduct	McDermott Will & Emery
16 Sep	Virulent Fraud: Abusing COVID-19 Relaxed Telehealth Rules for Medicare Fraud	Tycko & Zavareei LLP
15 Sep	FDA and FTC Coordination Appears to Be Escalating	Mintz
15 Sep	FDA and CDC Issue Warnings Regarding Health Risks of Using Delta-8 THC Products	Jackson Lewis P.C.
15 Sep	DC Court Revives Animal Welfare “Natural” Lawsuit	Keller and Heckman LLP
14 Sep	Marijuana Legalization Rundown: Recent Judicial Decisions	Epstein Becker & Green, P.C.
14 Sep	FDA & FTC Issue Warning Letters to 10 Companies	Keller and Heckman LLP
14 Sep	Crying Wolf: Fraudulent Diagnosis Inflation for Increased Medicare Part C Reimbursements	Tycko & Zavareei LLP
13 Sep	China Takes The Air Out of Excessive Packaging	Keller and Heckman LLP
13 Sep	President Biden Mandates Vaccines for Tens of Millions of Workers	Foley & Lardner LLP
13 Sep	Biden Administration’s Drug Pricing Plan Calls for Bold Action by Congress	Mintz
13 Sep	Rum Buyers Allege Package Makes False Age Claim	Keller and Heckman LLP
10 Sep	President Biden Issues COVID-19 Vaccine Mandate for Certain Workers and Federal Contractors and Subcontractors	Greenberg Traurig, LLP
10 Sep	Beltway Buzz, September 10, 2021: Vaccine Mandate; Federal Employment Law Changes	Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
10 Sep	Biden Administration Unveils Sweeping Workplace Vaccination Plan	Mintz
10 Sep	Locally Sourced Cannabis Laws: The Importance of Zoning in Cannabis Operations	Womble Bond Dickinson (US) LLP
10 Sep	White House Announces New Measures to Fight COVID-19 Pandemic	Miller Canfield
10 Sep	OSHA and CMS to Require Employers to Mandate Vaccines or Weekly Negative Tests	Squire Patton Boggs (US) LLP
10 Sep	White House Announces Vaccination Mandate or Weekly Testing for Large Employers, and Vaccination Mandate for Federal Employees and Contractors	Schiff Hardin LLP